Pioneering Medical Innovations
BEDFORD, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) — Ocular Therapeutix, Inc. (Nasdaq:OCUL) (the “Company”), a biopharmaceutical company committed to enhancing people’s vision and quality
Secured financing advances Instylla’s clinical trials and commercialization readiness BEDFORD, Mass., – August 15, 2023 – Instylla, Inc., a privately
NEWS PROVIDED BY TiE Global TiE Global Angels, led by TiE Boston, Invests $1.395M as part of a $20M Investment
Sealonix, a Bedford, MA-based developer of sealant products for abdominopelvic and orthopedic procedures, closed a $20m Series A financing.
Proceeds to accelerate commercialization and pipeline expansion of novel FLASH™ Aorto-Ostial Angioplasty System CAMPBELL, Calif., – Ostial Corporation (Ostial), a private medical
BEDFORD, Mass., Dec. 7, 2022 /PRNewswire/ — Rejoni announced today that it has closed a $25 million Series B financing. The round was led by Catalyst Health Ventures, with continued support from Ascension Health Ventures, Delos Capital, Sparta Group, Amed Ventures, and Iyengar Capital Partners.
Truvic CEO Mike Buck (left) with Imperative Care chairman and CEO Fred Khosravi (right). Credit: Business Wire. The funds will
Financing to see Instylla through US Pivotal and other clinical trials BEDFORD, Mass., Oct. 14, 2020 /PRNewswire/ — Instylla, Inc., a privately held
Funds to Fuel Commercialization of Breakthrough Technologies in Stroke Care to Enable Improved Patient Outcomes CAMPBELL, Calif.–(BUSINESS WIRE)–Imperative Care, Inc.
CAMPBELL, Calif., Jan. 13, 2015 /PRNewswire/ — Apama Medical, Inc., a privately held medical device company focused on the development of